BETR.CN
BetterLife Pharma Inc
Price:  
0.11 
CAD
Volume:  
60,920.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BETR.CN WACC - Weighted Average Cost of Capital

The WACC of BetterLife Pharma Inc (BETR.CN) is 8.7%.

The Cost of Equity of BetterLife Pharma Inc (BETR.CN) is 9.00%.
The Cost of Debt of BetterLife Pharma Inc (BETR.CN) is 5.00%.

Range Selected
Cost of equity 7.80% - 10.20% 9.00%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.6% - 9.8% 8.7%
WACC

BETR.CN WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.92 0.99
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.80% 10.20%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.06 0.06
Cost of debt 5.00% 5.00%
After-tax WACC 7.6% 9.8%
Selected WACC 8.7%